{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:43Z","timestamp":1792112683924,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T00:00:00Z","timestamp":1392768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["schres-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.schres.2014.01.043","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T18:00:36Z","timestamp":1393264836000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Atypical antipsychotics and hyperglycemic emergencies: Multicentre, retrospective cohort study of administrative data"],"prefix":"10.1016","volume":"154","author":[{"given":"Lorraine L.","family":"Lipscombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-7719","authenticated-orcid":false,"given":"Silvia","family":"Alessi-Severini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kawasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kurdyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 7","key":"10.1016\/j.schres.2014.01.043_bb0005","first-page":"22","article-title":"Antipsychotic-induced weight gain: a review of the literature","volume":"62","author":"Allison","year":"2001","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2014.01.043_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar. Behav. Res."},{"key":"10.1016\/j.schres.2014.01.043_bb0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2288-11-157","article-title":"Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee medicaid study","volume":"11","author":"Bobo","year":"2011","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"10.1016\/j.schres.2014.01.043_bb0020","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0895-4356(02)00588-7","article-title":"A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States","volume":"56","author":"Buse","year":"2003","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.schres.2014.01.043_bb0025","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4088\/JCP.v63n1208","article-title":"The risk of diabetes during olanzapine use compared with risperidone use: a retrospective database analysis","volume":"63","author":"Caro","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2014.01.043_bb0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/appi.ps.55.9.1006","article-title":"Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients","volume":"55","author":"Citrome","year":"2004","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0035","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/oxfordjournals.schbul.a033504","article-title":"Prevalence and correlates of diabetes in national schizophrenia samples","volume":"26","author":"Dixon","year":"2000","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2014.01.043_bb0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10401230701844612","article-title":"Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968\u20132004)","volume":"20","author":"DuMouchel","year":"2008","journal-title":"Ann. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0045","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0149-2918(03)80073-5","article-title":"Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders","volume":"25","author":"Gianfrancesco","year":"2003","journal-title":"Clin. Ther."},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.jcp.0000085404.08426.3a","article-title":"Antipsychotic-induced type 2 diabetes: evidence from a large health plan database","volume":"23","author":"Gianfrancesco","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2014.01.043_bb0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2146\/ajhp050144","article-title":"Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design","volume":"63","author":"Gianfrancesco","year":"2006","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"11","key":"10.1016\/j.schres.2014.01.043_bb0060","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2014.01.043_bb0065","series-title":"Product Monograph, Risperdal","author":"Janssen Inc.","year":"2013"},{"issue":"1","key":"10.1016\/j.schres.2014.01.043_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/10401230209147399","article-title":"Phenomenology of and risk factors for new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases","volume":"14","author":"Jin","year":"2002","journal-title":"Ann. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0075","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1345\/aph.1K607","article-title":"Rapidly developing hyperglycemia during treatment with olanzapine","volume":"42","author":"Kohen","year":"2008","journal-title":"Ann. Pharmacother."},{"issue":"7","key":"10.1016\/j.schres.2014.01.043_bb0080","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1592\/phco.22.11.841.33629","article-title":"Olanzapine-associated diabetes mellitus","volume":"22","author":"Koller","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.schres.2014.01.043_bb0085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1592\/phco.23.6.735.32178","article-title":"Risperidone-associated diabetes mellitus: a pharmacovigilance study","volume":"23","author":"Koller","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"6","key":"10.1016\/j.schres.2014.01.043_bb0090","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4088\/JCP.v65n0619","article-title":"A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus","volume":"65","author":"Koller","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2014.01.043_bb0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4088\/JCP.v63n0902","article-title":"Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database","volume":"63","author":"Kornegay","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"7358","key":"10.1016\/j.schres.2014.01.043_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","article-title":"Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case\u2013control study","volume":"325","author":"Koro","year":"2002","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.schres.2014.01.043_bb0105","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1176\/appi.ajp.161.9.1709","article-title":"Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications","volume":"161","author":"Leslie","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2014.01.043_bb0110","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.160.2.290","article-title":"Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics","volume":"160","author":"Lindenmayer","year":"2003","journal-title":"Am. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.schres.2014.01.043_bb0115","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archinternmed.2009.207","article-title":"Antipsychotic drugs and hyperglycemia in older patients with diabetes","volume":"169","author":"Lipscombe","year":"2009","journal-title":"Arch. Intern. Med."},{"issue":"12","key":"10.1016\/j.schres.2014.01.043_bb0120","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/JGP.0b013e318209dd24","article-title":"Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study","volume":"19","author":"Lipscombe","year":"2011","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"9","key":"10.1016\/j.schres.2014.01.043_bb0125","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.28.9.1198","article-title":"Diabetic ketoacidosis associated with aripiprazole","volume":"28","author":"Makhzoumi","year":"2008","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.schres.2014.01.043_bb0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/SMJ.0b013e31804b1e4d","article-title":"New onset diabetes with ketoacidosis attributed to quetiapine","volume":"100","author":"Marlowe","year":"2007","journal-title":"South. Med. J."},{"issue":"7","key":"10.1016\/j.schres.2014.01.043_bb0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","article-title":"Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research","volume":"47","author":"Moride","year":"1994","journal-title":"J. Clin. Epidemiol."},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0140","first-page":"278","article-title":"Diabetes mellitus associated with atypical antipsychotic medications: new case report and review of the literature","volume":"14","author":"Muench","year":"2001","journal-title":"J. Am. Board Fam. Pract."},{"issue":"3","key":"10.1016\/j.schres.2014.01.043_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/10401230600801234","article-title":"Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies","volume":"18","author":"Ramaswamy","year":"2006","journal-title":"Ann. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2014.01.043_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/00002018-200730070-00004","article-title":"Risk of diabetic ketoacidosis after exposure to risperidone or olanzapine","volume":"30","author":"Ramaswamy","year":"2007","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.schres.2014.01.043_bb0155","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1345\/aph.10178","article-title":"Olanzapine-lnduced hyperglycemic nonketonic coma","volume":"35","author":"Roefaro","year":"2001","journal-title":"Ann. Pharmacother."},{"issue":"9","key":"10.1016\/j.schres.2014.01.043_bb0160","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0165","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","article-title":"Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia","volume":"159","author":"Sernyak","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2014.01.043_bb0170","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1192\/bjp.bp.107.037184","article-title":"First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis","volume":"192","author":"Smith","year":"2008","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0175","first-page":"e134","article-title":"CNODES: the Canadian Network for Observational Drug Effect Studies","volume":"6","author":"Suissa","year":"2012","journal-title":"Open Med."},{"issue":"4","key":"10.1016\/j.schres.2014.01.043_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2005-871245","article-title":"Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report","volume":"38","author":"Takahashi","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.schres.2014.01.043_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00331-0","article-title":"New-onset diabetes and ketoacidosis with atypical antipsychotics","volume":"59","author":"Wilson","year":"2003","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996414000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T07:23:12Z","timestamp":1538810592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996414000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":37,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0920996414000681"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2014.01.043","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical antipsychotics and hyperglycemic emergencies: Multicentre, retrospective cohort study of administrative data","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2014.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}